TWC
VNDA icon

TD Waterhouse Canada’s Vanda Pharmaceuticals VNDA Stock Holding History

TD Waterhouse Canada’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78K Hold
294
– – ﹤0.01% 2134
2026
Q1 		$2.07K Buy
+294
New +$2.27K ﹤0.01% 2039
2022
Q4 		– Sell
-503
Closed -$5.08K – 1783
2022
Q3 		$5.08K Sell
503
-174
-26% -$1.84K ﹤0.01% 1353
2022
Q2 		$7.56K Buy
677
+167
+33% +$1.73K ﹤0.01% 1309
2022
Q1 		$6.03K Buy
510
+174
+52% +$2.29K ﹤0.01% 1420
2021
Q4 		$5.47K Buy
+336
New +$5.86K ﹤0.01% 1440

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

TD Waterhouse Canada's VNDA Position: Q2 2026 in Review

TD Waterhouse Canada held its Vanda Pharmaceuticals (VNDA) position steady in Q2 2026 at 294 shares worth $1.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

TD Waterhouse Canada first reported a position in VNDA in Q4 2021 and has held it in 6 quarters since. The position peaked at $7.56K in Q2 2022. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • TD Waterhouse Canada held 294 shares of Vanda Pharmaceuticals worth $1.78K as of Q2 2026.
  • TD Waterhouse Canada left its Vanda Pharmaceuticals share count unchanged in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2134 holding.
  • TD Waterhouse Canada first reported a position in Vanda Pharmaceuticals in Q4 2021 and has held it in 6 quarters since.
  • TD Waterhouse Canada's Vanda Pharmaceuticals position peaked at $7.56K in Q2 2022.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.